Equity Research, Broker Reports, and media content on Oncimmune

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oncimmune
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oncimmune. We currently have 35 research reports from 6 professional analysts.

Open
N/A
Range Today
N/A
52 Week
44.0/125p
Daily Volume
N/A
# Shares
63.2m
Daily Liquidity
(0.01%)
Pension Liability
£0m
Enterprise Value
£35.8m
Market Cap
£28.5m
Latest PE (hist)
Div Yield
Date Source Announcement
12Dec19 14:07 RNS-R Winner of BioNewsRound Award
29Nov19 09:58 RNS Results of Annual General Meeting
04Nov19 14:46 RNS Notice of AGM and Posting of Annual Report
04Nov19 07:00 RNS Draw down of second tranche of credit facility
01Nov19 07:10 RNS Oncimmune and Biodesix seal deal
31Oct19 07:00 RNS Final Results
25Oct19 07:00 RNS Notice of Full Year Results ended May 2019
  • Frequency of research reports

     

  • Research reports on

    Oncimmune

  • Providers covering

    Oncimmune